Eduard Grebe

1.5k total citations · 1 hit paper
75 papers, 718 citations indexed

About

Eduard Grebe is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Eduard Grebe has authored 75 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Infectious Diseases, 23 papers in Virology and 17 papers in Epidemiology. Recurrent topics in Eduard Grebe's work include HIV/AIDS Research and Interventions (33 papers), HIV Research and Treatment (23 papers) and SARS-CoV-2 and COVID-19 Research (17 papers). Eduard Grebe is often cited by papers focused on HIV/AIDS Research and Interventions (33 papers), HIV Research and Treatment (23 papers) and SARS-CoV-2 and COVID-19 Research (17 papers). Eduard Grebe collaborates with scholars based in United States, South Africa and United Kingdom. Eduard Grebe's co-authors include Nicoli Nattrass, Michael P. Busch, Alex Welte, Mars Stone, Shelley N. Facente, Clara Di Germanio, Gary Murphy, Christopher D. Pilcher, Jefferson M. Jones and Reshma Kassanjee and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Eduard Grebe

65 papers receiving 681 citations

Hit Papers

Estimates of SARS-CoV-2 Seroprevalence and Incidence of P... 2023 2026 2024 2025 2023 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eduard Grebe United States 16 511 199 177 103 69 75 718
Shelley N. Facente United States 18 542 1.1× 402 2.0× 346 2.0× 67 0.7× 16 0.2× 52 878
Hamish McManus Australia 15 351 0.7× 137 0.7× 378 2.1× 99 1.0× 15 0.2× 58 706
Ann McDonald Australia 19 788 1.5× 364 1.8× 692 3.9× 191 1.9× 88 1.3× 41 1.3k
Larry Han United States 18 466 0.9× 97 0.5× 440 2.5× 191 1.9× 29 0.4× 44 1.1k
Sombat Thanprasertsuk Thailand 14 658 1.3× 265 1.3× 442 2.5× 239 2.3× 22 0.3× 20 865
Arielle Lasry United States 13 627 1.2× 192 1.0× 463 2.6× 184 1.8× 10 0.1× 28 975
N. Kumarasamy India 20 638 1.2× 346 1.7× 319 1.8× 62 0.6× 11 0.2× 36 925
Dereje Bayissa Demissie Ethiopia 10 255 0.5× 122 0.6× 126 0.7× 17 0.2× 41 0.6× 38 536
Hong‐Ha M. Truong United States 17 760 1.5× 276 1.4× 531 3.0× 250 2.4× 18 0.3× 60 929
Peter Saxton New Zealand 15 522 1.0× 45 0.2× 578 3.3× 263 2.6× 22 0.3× 69 1.1k

Countries citing papers authored by Eduard Grebe

Since Specialization
Citations

This map shows the geographic impact of Eduard Grebe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduard Grebe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduard Grebe more than expected).

Fields of papers citing papers by Eduard Grebe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eduard Grebe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduard Grebe. The network helps show where Eduard Grebe may publish in the future.

Co-authorship network of co-authors of Eduard Grebe

This figure shows the co-authorship network connecting the top 25 collaborators of Eduard Grebe. A scholar is included among the top collaborators of Eduard Grebe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eduard Grebe. Eduard Grebe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grebe, Eduard, Clara Di Germanio, Edward P. Notari, et al.. (2025). HIV incidence in US first‐time blood donors during 12 and 3 month deferral policy periods between 2015 and 2023 before implementation of individual donor assessment. Transfusion. 65(5). 834–840. 2 indexed citations
3.
Bruhn, Roberta, et al.. (2024). Adherence to COVID‐19 vaccination recommendations and vaccine hesitancy in US blood donors. Transfusion. 64(12). 2314–2324. 2 indexed citations
4.
Germanio, Clara Di, Xutao Deng, Eduard Grebe, et al.. (2024). Performance of a rapid recency assay for detection of early HIV infection. Journal of Clinical Virology. 174. 105708–105708. 1 indexed citations
5.
Avelino‐Silva, Vivian I., Roberta Bruhn, Xutao Deng, et al.. (2024). SARSCoV‐2 antibody levels and long COVID occurrence in blood donors. Transfusion. 64(9). 1719–1731. 2 indexed citations
6.
Sulaeman, Hasan, Eduard Grebe, Honey Dave, et al.. (2023). Evaluation of Ortho VITROS and Roche Elecsys S and NC Immunoassays for SARS-CoV-2 Serosurveillance Applications. Microbiology Spectrum. 11(4). e0323422–e0323422. 8 indexed citations
8.
Facente, Shelley N., Eduard Grebe, Susan Scheer, et al.. (2022). Use of HIV Recency Assays for HIV Incidence Estimation and Other Surveillance Use Cases: Systematic Review. JMIR Public Health and Surveillance. 8(3). e34410–e34410. 18 indexed citations
9.
Facente, Shelley N., Roberta Bruhn, Zhanna Kaidarova, et al.. (2022). Hepatitis C prevalence and key population size estimate updates in San Francisco: 2015 to 2019. PLoS ONE. 17(5). e0267902–e0267902. 1 indexed citations
10.
Vermeulen, Marion, Cari van Schalkwyk, Karin van den Berg, et al.. (2022). The Impact of Early Antiretroviral Treatment (ART) for HIV on the Sensitivity of the Latest Generation of Blood Screening and Point of Care Assays. Viruses. 14(7). 1426–1426. 4 indexed citations
11.
Grebe, Eduard, Valerie Green, Alyce Linthurst Jones, et al.. (2022). Low rate of detection of SARS-CoV-2 RNA in deceased tissue donors. Cell and Tissue Banking. 24(3). 585–596. 1 indexed citations
12.
Berg, Karin van den, Marion Vermeulen, Sonia Bakkour, et al.. (2022). Blood Center Testing Allows the Detection and Rapid Treatment of Acute and Recent HIV Infection. Viruses. 14(11). 2326–2326.
13.
Germanio, Clara Di, Graham Simmons, Kathleen Kelly, et al.. (2021). SARS‐CoV ‐2 antibody persistence in COVID ‐19 convalescent plasma donors: Dependency on assay format and applicability to serosurveillance. Transfusion. 61(9). 2677–2687. 29 indexed citations
14.
Meyer, Erin, Graham Simmons, Eduard Grebe, et al.. (2021). Selecting COVID ‐19 convalescent plasma for neutralizing antibody potency using a high‐capacity SARS‐CoV ‐2 antibody assay. Transfusion. 61(4). 1160–1170. 12 indexed citations
15.
Grebe, Eduard, et al.. (2021). Factors driving availability of COVID ‐19 convalescent plasma: Insights from a demand, production, and supply model. Transfusion. 61(5). 1370–1376. 2 indexed citations
16.
Facente, Shelley N., Eduard Grebe, Christopher D. Pilcher, et al.. (2020). Estimated dates of detectable infection (EDDIs) as an improvement upon Fiebig staging for HIV infection dating. Epidemiology and Infection. 148. e53–e53. 6 indexed citations
17.
Grebe, Eduard, Michael P. Busch, Edward P. Notari, et al.. (2020). HIV incidence in US first-time blood donors and transfusion risk with a 12-month deferral for men who have sex with men. Blood. 136(11). 1359–1367. 15 indexed citations
18.
Facente, Shelley N., Michael P. Busch, Eduard Grebe, et al.. (2019). Challenges to the performance of current HIV diagnostic assays and the need for centralized specimen archives: a review of the Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA) repository. SHILAP Revista de lepidopterología. 3. 1511–1511. 1 indexed citations
19.
Sempa, Joseph B., Alex Welte, Michael P. Busch, et al.. (2019). Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillance. PLoS ONE. 14(7). e0220345–e0220345. 17 indexed citations
20.
Grebe, Eduard, et al.. (2018). Infection Dating Tool. Zenodo (CERN European Organization for Nuclear Research). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026